Cohort study2026

Axial and choroidal changes as key predictors of myopia control in red-light therapy: Evidence from machine learning models

Hu X, Wang Z, Li R, Sun B, Wang D, Zong H, Zhang X, Wei R, Jie H

Photodiagnosis and photodynamic therapy · 1 citation

Review labels

Funding not disclosed

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Cohort study (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function

Who paid for it

Funding
Funding not disclosed

Publication

Published
2026-01-08 · Photodiagnosis Photodyn Ther · vol. 57 · p. 105342
Publisher
Elsevier BV
Cited
3 citations · more than 99% of similar papers · 16.4× the field average
Impact
Top 10% most cited in its field
References
46 works
Access
Open access (journal) · CC-BY-NC-ND
Research areas
Ophthalmology and Visual Impairment Studies · Retinal Diseases and Treatments · Corneal surgery and disorders
Keywords
Key (lock), Control (management), Foundation (evidence), Deep learning
MeSH
choroid, humans, myopia, sensitivity and specificity, cohort studies, adolescent, child, female, male, axial length, eye, machine learning, red light, boosting machine learning algorithms, predictive learning models

9 authors

From CN

  • Xiaoxue HuWuhan Children's Hospital; Huazhong University of Science and Technology
  • Zixun WangTianjin Medical University Eye Hospital; Tianjin Medical University
  • Rui LiThe Central Hospital of Xiao gan
  • Boxuan SunTianjin Medical University Eye Hospital; Tianjin Medical University
  • D. X. WangWuhan Children's Hospital; Huazhong University of Science and Technology
  • Hui ZongWuhan Children's Hospital; Huazhong University of Science and Technology

Abstract

Background

Repeated low-level red-light (RLRL) therapy has emerged as a promising non-invasive intervention for myopia control. However, the predictive factors underlying its efficacy remain insufficiently explored.

Methods

This multicenter cohort study included 538 pediatric patients who underwent RLRL treatment with a minimum follow-up of one year. Baseline ocular parameters and dynamic changes in axial length (AL) and choroidal thickness (ChT) over three months were collected. Multiple feature selection approaches-LASSO regression, Boruta, recursive elimination, and multivariate regression-were applied. Seven machine learning algorithms were trained, and their performance was evaluated using the area under the curve (AUC), sensitivity, specificity, and F1 score. SHAP and LIME analyses were utilized for interpretability.

Results

Logistic regression and gradient boosting models demonstrated the highest discriminative ability. XGBoost achieved optimal performance (AUC: 0.90-0.92; accuracy: 87.7-88.2 %; F1 score: 0.72-0.86). Across one- and two-year prediction models, six stable predictors were identified: age, baseline AL, anterior chamber depth (ACD), RNFL thickness at the temporal inferior quadrant (TI), ChangeAL, and ChangeChT. SHAP analysis revealed that ChangeAL was the dominant short-term predictor, whereas ChangeChT was most influential for long-term outcomes. Older age and greater choroidal thickening were consistently associated with a protective effect against myopia progression.

Conclusions

We developed and validated an interpretable machine learning model that accurately predicts short- and long-term outcomes of RLRL therapy in children. ChangeAL and ChangeChT serve as key dynamic biomarkers for treatment monitoring. These findings provide a foundation for personalized clinical decision-making in myopia management.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-ND).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.